Miami Cancer Institute Researchers Present Latest Findings at 2025 Annual Meeting of the American Society for Radiation Oncology

MIAMI, FL & SAN DIEGO, CA – August 14, 2025 – Miami Cancer Institute, part of Baptist Health South Florida, today announced its presentations at the 67th American Society for Radiation Oncology (ASTRO) Annual Meeting, September 27 – October 1, 2025, at the Moscone Center in San Francisco, California. The presentations focus on emerging advancements and nuanced evaluations in radiation oncology, innovations in proton and MR-guided adaptive radiotherapy, treatment planning and outcomes for gastrointestinal and brain cancers, automated imaging segmentation tools, motion management, and biological modeling of treatment risks.
 
“We have a wide array of impactful presentations at this year’s ASTRO annual meeting,” said Minesh P. Mehta, M.D., deputy director and chief of radiation oncology at Miami Cancer Institute. “Our presentations underscore Miami Cancer Institute’s commitment to precision, innovation, and evidence-based care – advancing how we plan, deliver, and adapt radiation therapy for complex and challenging cancers. In addition to our presentations at ASTRO, we have an educational session on ablative radiation therapy for pancreas cancer.”

Miami Cancer Institute researchers will have three oral and eight poster presentations, participate in three quick pitches, and join one educational session at ASTRO 2025:

Oral Presentation

Monday, September 29, 2025
A Deep Quantitative Assessment of Metabolic Mucosal Changes with Variable Relative Biological Effectiveness of Head and Neck Proton Therapy
Presenter: Sreenija Yarlagadda, M.D.
Time: 11:15 a.m. – 11:25 a.m. PT
Location: Room 22/23

Tuesday, September 30, 2025
Definitive Stereotactic Body Radiation Therapy for Resectable Non-Metastatic Pancreatic Ductal Adenocarcinoma: A Multi-Center Retrospective Analysis
Presenter: Michael Chuong, M.D.
Time: 08:00 a.m. – 09:00 a.m. PT
Location: Room 156/158

Plan Quality Reporting of the Phase II Stereotactic MR-Guided Adaptive Radiation Therapy in One Fraction (SMART ONE) Trial
Presenter: Kathryn Mittauer, Ph.D.
Time: 12:45 p.m. – 02:00 p.m. PT
Location: Room 307/308

Signal-Seeking P2R Trial of Proton or IMRT Dose Intensification in GBM: NGR-BN001
Presenter: Minesh Mehta, MD, MB, ChB, FASTRO
Time: 3:33 – 3:42 p.m. PT
Location: Room 22/23

Poster Presentations

Sunday, September 28, 2025
Decoding Auto-Segmentation: A Deep Qualitative Analysis of Commercial Tools for Organs-at-Risk Delineation
Presenter: Ranjini Tolakanahalli,PhD, DABR
Time: 02:30 p.m. – 04:00 p.m. PT
Poster #: 2003
Location: Hall F

Dosimetric Evaluation of Proton Arc Therapy for Chest Wall Radiation in Patients with Tissue Expanders
Presenter: Andrew Wroe, PhD, DABR
Time: 02:30 p.m. – 04:00 p.m. PT
Poster #: 2174
Location: Hall F

Monday, September 29, 2025
Comparative Evaluation of Tile Estimation Workflows for STaRT Pre-Planning in Patients with Recurrent Brain Metastasis
Presenter: Vibha Chaswal, Ph.D., DABR
Time: 08:00 a.m. – 09:00 a.m. PT
Poster #: 2574
Location: Hall F

Normal Tissue Complication Probability Model Predicting the Risk of Radiation Necrosis after Stereotactic Radiosurgery for Small Brain Metastases
Presenter: Sreenija Yarlagadda, M.D.
Time: 08:00 a.m. – 09:00 a.m. PT
Poster #: 2677
Location: Hall F

Timing and Predictors of Grade 3 Lymphopenia in Lung Cancer Patients Undergoing Proton Chemoradiotherapy
Presenter: Sreenija Yarlagadda, M.D.
Time: 05:00 p.m. – 06:00 p.m. PT
Poster #: 3020
Location: Hall F

Tuesday, September 30, 2025
Dose-Escalated Intensity Modulated Proton Therapy (IMPT) for Node-Positive Prostate Cancer – First Report of Clinical Outcomes
Presenter: Marcio Fagundes, M.D.
Time: 12:45 p.m. – 02:00 p.m. PT
Poster #: 3220
Location: Hall F

Outcomes with Salvage Dose-Escalated Intensity Modulated Proton Therapy in Node-Positive Recurrence after Prostatectomy
Presenter: Amna Gul, M.D.
Time: 12:45 p.m. – 02:00 p.m. PT
Poster #: 3241
Location: Hall F

Impact of Subcutaneous and Visceral Fat in Patients Receiving Ablative Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Cancer
Presenter: Adeel Kaiser, M.D.
Time: 02:30 p.m. – 03:45 p.m. PT
Poster #: 3454
Location: Hall F

Quick Pitch Presentations

Tuesday, September 30, 2025
Radiation Therapy Alone vs. Radiation Therapy Plus Radiofrequency Ablation/Vertebral Augmentation for Painful Spine Metastasis: A Randomized Controlled Trial
Presenter: Rupesh Kotecha, M.D.
Time: 12:45 p.m. – 02:00 p.m. PT
Location: Room 310-312

Does Pencil Beam Scanning Proton Therapy Impart a Higher Risk of Capsular Contracture when Compared with Intensity Modulated Photon Radiotherapy in the Post-Mastectomy Reconstruction Setting?
Presenter: Joseph Panoff, M.D., M.A.
Presentation #: 1060
Time: 04:00 p.m. – 05:00 p.m. PT
Location: Room 24

Wednesday, October 1, 2025
Radiation and Cancer Physics 9: Motion Management
Presenter: Kathryn Mittauer, Ph.D.
Time: 08:00 a.m. – 09:00 a.m. PT
Location: Room 160

GI 5: Quick Pitch: ROTF LMAO with pancreatic and liver - Recurrences and Outcomes, Technological Feats,  Latest Modalities, and Adapting Online
Presenter: Michael Chuong, M.D.
Time: 10:30 a.m. – 11:30 a.m. PT
Location: Room 155/157

Education Sessions

Sunday, September 28, 2025
Ablative Radiation Therapy for Locally Advanced Pancreas Cancer: Clinical Indications and Practical Considerations
Presenter: Michael Chuong, M.D.
Time: 07:55 a.m. – 09:15 a.m. PT
Location: Room 301-304

For updates from the ASTRO 2025 Annual Meeting, look for #ASTRO2025 on social media and follow Miami Cancer Institute on X (Twitter) at @MiamiCancerInst.

###

About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK. For more information, please visit https://baptisthealth.net/services/cancer-care/miami-cancer-institute.

Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches.